RenovoRx RNXT
NASDAQ RNXT
$1.77 -0.23 (-11.28%)
At close: Sep 10, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Net Shares Issued and Repurchased (2021 - 2026)

RenovoRx's (RNXT) quarterly Net Shares Issued and Repurchased came in at $12000.0 in Q1 2026, down 76.92% year-over-year from $52000.0 in Q1 2025, and down 99.35% quarter-over-quarter from $1.8 million in Q4 2025.

Analysis

RenovoRx (RNXT) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends

RenovoRx has disclosed Net Shares Issued and Repurchased across 6 years of filings, most recently posting $12000.0 for Q1 2026.

  • In Q1 2026, Net Shares Issued and Repurchased fell 76.92% year-over-year to $12000.0; the TTM figure through Mar 2026 stood at $12000.0 (down 76.92% YoY), while the FY2025 annual figure was $1.8 million, up 19.7% from the prior year.
  • Net Shares Issued and Repurchased came in at $12000.0 for Q1 2026 at RenovoRx, down from $1.8 million in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $724.9 million in Q4 2022 to a low of $12000.0 in Q1 2026.
  • Average Net Shares Issued and Repurchased over 5 years is $81.2 million, with a median of $552096.0 recorded in 2023.
  • Year-over-year, Net Shares Issued and Repurchased jumped 232064.09% in 2022 and tumbled 99.92% in 2023.
  • Over 5 years, Net Shares Issued and Repurchased stood at $724.9 million in 2022, then plunged by 99.92% to $552096.0 in 2023, then jumped by 179.3% to $1.5 million in 2024, then gained by 19.7% to $1.8 million in 2025, then sank by 99.35% to $12000.0 in 2026.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $12000.0 in Q1 2026, $1.8 million in Q4 2025, and $52000.0 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn -
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn -
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn -
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -
10 RenovoRx 83.48 Mn 83.48 Mn 766,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 12,000.00
Dec 31, 2025 1.85 Mn
Mar 31, 2025 52,000.00
Dec 31, 2024 1.54 Mn
Mar 31, 2024 1.11 Mn
Dec 31, 2023 552,096.00
Mar 31, 2023 304,325.00
Dec 31, 2022 724.94 Mn
Mar 31, 2022 159,041.00
Dec 31, 2021 312,252.00